Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.

King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, Lombroso P, Scahill L.

J Am Acad Child Adolesc Psychiatry. 1991 Mar;30(2):179-86.

PMID:
2016219
[PubMed - indexed for MEDLINE]
2.

Fluoxetine: no association with suicidality in obsessive-compulsive disorder.

Beasley CM Jr, Potvin JH, Masica DN, Wheadon DE, Dornseif BE, Genduso LA.

J Affect Disord. 1992 Jan;24(1):1-10.

PMID:
1545040
[PubMed - indexed for MEDLINE]
3.

Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.

Tollefson GD, Fawcett J, Winokur G, Beasley CM Jr, Potvin JH, Faries DE, Rampey AH Jr, Sayler ME.

Ann Clin Psychiatry. 1993 Dec;5(4):209-24. Review.

PMID:
8312978
[PubMed - indexed for MEDLINE]
4.

Lack of association between fluoxetine and suicidality in bulimia nervosa.

Wheadon DE, Rampey AH Jr, Thompson VL, Potvin JH, Masica DN, Beasley CM Jr.

J Clin Psychiatry. 1992 Jul;53(7):235-41.

PMID:
1639742
[PubMed - indexed for MEDLINE]
5.

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.

Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.

J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1062-9.

PMID:
1429406
[PubMed - indexed for MEDLINE]
6.

More on self mutilation and obsessive compulsive disorder.

Hollander E, Papp L, Campeas R, DeCaria C, Liebowitz MR.

Can J Psychiatry. 1988 Oct;33(7):675. No abstract available.

PMID:
3058294
[PubMed - indexed for MEDLINE]
7.

Fluoxetine treatment of obsessive-compulsive disorder.

Turner SM, Jacob RG, Beidel DC, Himmelhoch J.

J Clin Psychopharmacol. 1985 Aug;5(4):207-12.

PMID:
3894437
[PubMed - indexed for MEDLINE]
8.

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.

Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN.

BMJ. 1991 Sep 21;303(6804):685-92. Erratum in: BMJ 1991 Oct 19;303(6808):968.

PMID:
1833012
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Fluoxetine and suicidal ideation.

Koizumi H.

J Am Acad Child Adolesc Psychiatry. 1991 Jul;30(4):695. No abstract available.

PMID:
1890110
[PubMed - indexed for MEDLINE]
10.

Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.

Riddle MA, Hardin MT, King R, Scahill L, Woolston JL.

J Am Acad Child Adolesc Psychiatry. 1990 Jan;29(1):45-8.

PMID:
2295577
[PubMed - indexed for MEDLINE]
11.

Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.

Bodfish JW, Madison JT.

Am J Ment Retard. 1993 Nov;98(3):360-7.

PMID:
8292312
[PubMed - indexed for MEDLINE]
12.

Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy.

Primeau F, Fontaine R.

Can J Psychiatry. 1987 Nov;32(8):699-701.

PMID:
3500773
[PubMed - indexed for MEDLINE]
13.

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.

JAMA. 2007 Apr 18;297(15):1683-96.

PMID:
17440145
[PubMed - indexed for MEDLINE]
14.

A double-blind trial of fluoxetine in pathologic skin picking.

Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E.

J Clin Psychiatry. 1997 Aug;58(8):341-7.

PMID:
9515971
[PubMed - indexed for MEDLINE]
15.

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.

Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL.

Arch Gen Psychiatry. 1990 Oct;47(10):926-32.

PMID:
2222131
[PubMed - indexed for MEDLINE]
16.

Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study.

Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW, Leckman JF.

J Child Adolesc Psychopharmacol. 1997 Summer;7(2):75-85.

PMID:
9334893
[PubMed - indexed for MEDLINE]
17.

Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.

Tauscher-Wisniewski S, Disch D, Plewes J, Ball S, Beasley CM.

Psychol Med. 2007 Nov;37(11):1585-93. Epub 2007 Jul 20. Review.

PMID:
17640442
[PubMed - indexed for MEDLINE]
18.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
[PubMed - indexed for MEDLINE]
19.

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.

Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL.

Am J Psychiatry. 1993 May;150(5):819-21.

PMID:
8480832
[PubMed - indexed for MEDLINE]
20.

Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?

Koran LM, Cain JW, Dominguez RA, Rush AJ, Thiemann S.

Am J Psychiatry. 1996 Nov;153(11):1450-4.

PMID:
8890679
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk